Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients

NCT00493870 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.

NCT NCT00493870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00493870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Lead sponsor
US Oncology Research
Phase
Phase 3
Overall status
Completed
Start date
May 29, 2007
Completion date
March 30, 2020
Enrollment
1,961 (actual)
Sites
95

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer